Related Experiment Video
Updated: May 17, 2026

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats
Published on: March 28, 2025
Hospital use, associated costs, and payer status for infants born with spina bifida
Elizabeth Radcliff1, Cynthia H Cassell, Jean Paul Tanner
1Department of Public Health Sciences, University of North Carolina at Charlotte, Charlotte, North Carolina 28223, USA. eradclif@uncc.edu
Insights
A small group of infants with spina bifida (SB) experience multiple hospitalizations and high healthcare costs within their first year. Public payers covered nearly 60% of these hospitalizations.
Area of Science:
- Pediatric Health Outcomes
- Public Health Policy
- Healthcare Economics
Background:
- Children with spina bifida (SB) incur higher healthcare utilization and costs than unaffected children.
- Limited data exists on hospital use and associated costs for infants with SB across different health insurance payer types.
- Understanding these costs is crucial for resource allocation and policy development.
Purpose of the Study:
- To examine hospitalizations and associated costs in the first year of life for infants with spina bifida (SB).
- To analyze these costs based on sociodemographic characteristics and health insurance payer types.
- To investigate changes in health insurance payer status among these infants.
Main Methods:
- Retrospective, population-based analysis of Florida infants born with SB (1998-2007).
- Data linkage between the Florida Birth Defects Registry and hospital discharge records.
- Calculation of hospitalizations, length of stay, and estimated costs, stratified by demographics and payer type.
Main Results:
- 615 infants with SB averaged 2.4 hospitalizations and 25.2 days in the hospital during their first year.
- Approximately 18% of infants had over three hospitalizations.
- Public payer sources covered almost 60% of hospitalizations, with mean costs of $39,059 per infant.
Conclusions:
- A small proportion of infants with spina bifida account for a significant number of hospitalizations and high costs.
- Further research is needed to identify factors influencing length of stay, hospitalization frequency, and overall costs.
- Findings highlight the substantial economic burden associated with SB care in infancy.
Background:
Health care use and costs for children with spina bifida (SB) are significantly greater than those of unaffected children. Little is known about hospital use and costs across health insurance payer types. We examined hospitalizations and associated costs by sociodemographic characteristics and payer type during the first year of life among children with SB. We also examined changes in health insurance payer status.
Methods:
This study was a retrospective, statewide population-based analysis of infants with SB without anencephaly born in Florida during 1998-2007. Infants were identified by the Florida Birth Defects Registry and linked to hospital discharge records. Descriptive statistics on number of hospitalizations, length of stay, and estimated hospital costs per hospitalization and per infant were calculated during the first year of life. Results were stratified by selected sociodemographic variables and health insurance payer type.
Results:
Among 615 infants with SB, mean and median numbers of hospitalizations per infant were 2.4 and 2.0, respectively. Mean and median total days of hospitalization per infant were 25.2 and 14.0 days, respectively. Approximately 18% of infants were hospitalized more than three times. Among infants with multiple hospitalizations, 16.7% had a mix of public and private health insurance payers. Almost 60% of hospitalizations for infants were paid by public payer sources. Mean and median estimated hospital costs per infant were $39,059 and $21,937, respectively.
Conclusions:
Results suggest a small percentage of infants with SB have multiple hospitalizations with high costs. Further analysis on factors associated with length of stay, hospitalizations, and costs is warranted.
More Related Videos
Related Concept Videos
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Neurulation
Teratogenicity
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...

